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Aortoiliac Disease-Endovascular Treatment
For a detailed discussion of endovascular treatment
of aortoiliac disease, see B 4.3.2, Aortoiliac PTA, p
583. Endovascular techniques such as PTA and stent
placement have the advantage of lower morbidity
and mortality risk compared with open surgical
revascularisations.' The death and complication
rates of aortoiliac PTA and stent placement were
analysed ' in a meta-analysis of 2,116 reported
patlents.? Death within hospital stay (not 30-day
mortality) averaged 0.14% for PTA and 0.3% for
stent procedures. The 30-day mortality rate aver-
aged 0.8% for PTA and 1.0% for stent procedures
(For detailed discussion of complications of
endovascular procedures, see B 4.3.7, P 5109). The
mean systemic complication rate was 1.3%; the local
complication rate, 9.6%; and the mean rate of major
complications necessitating treatment was 4.3% for
PTA and 5.2% for stents, respectively>
Endovascular procedures are generally performed
on patients with less severe disease than those
undergoing surgical treatment. The risk for endovas-
cular technique is much lower than for surgical
treatment. However, PTA and stents offer a lower
durability of the result as compared with bifurcated
graft surgery. The adjusted 4-year primary patency
rate for treatment of CLI, with technical failures
included, was 53% after PTA and 67% after stent
placement for the treatment of stenoses.s-' Analysis
of variables that could potentially affect the patency
results shown some heterogeneity. However, disease
severity (CLI vs claudication), lesion type (occlusion
vs stenosis), and lesion site (common vs external
iliac) were found to affect patency in some studies.v'
An analysis of the results of the endovascular
treatment of aortoiliac disease has already been pre-
sented (see B4.3.2, Aortoiliac PTA, p 583, and B 4.3.3,
Aortoiliac Stents, p 586) and is not repeated here.
This is because these procedures have been predom-
inantly performed for claudication (proportion of
patients undergoing procedures for claudication:
77% of PTA performed for iliac stenoses, 82% of iliac
PTA for occlusions, 78% of iliac stenting for stenosis,
and 86% of iliac stenting for occlusion). It should
therefore be pointed out, in reviewing these data in
comparison with the surgical bypass data presented
earlier (see D 4.5.3, P 5174), that the iliac PTA and
stent data primarily reflect the treatment of unilater-
al (iliac) disease, with lesions amenable to these
modalities.
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Introduction to Preferred Therapeutic Options
The decision about what type of revascularisation to
recommend ideally should be made by a multidisci-
plinary team. Important issues that may influence the
recommended decision are :
• lesion morphology
• risk of surgery for that particular patient
• previous procedures (ie, bypass or angioplasty)
• patient's life expectancy
• local expertise and experience with particular sur-
gical or endovascular procedures
In general, endovascular procedures are safer and
require shorter hospitalisation compared with surgical
procedures. Durability of these endovascular proce-
dures is, however, less well established. For most
lesions, there is no direct evidence comparing the
results of endovascular or surgical treatment in a con-
trolled, prospective, randomised study.
The system used for preferred therapeutic options
has been detailed (see B 4.3, Endovascular Procedures
for Intermittent Claudication, p 582). Lesions are
defined and then placed in four groups, each group
usually being treated in a similar way. The two
extremes are type A lesions, in which endovascular
approach is the treatment of choice, and type D
lesions, in which surgery is the treatment of choice . In
between these two groups are types Band C lesions, in
which no firm recommendations can be made about
the preferred interventional option. However,
endovascular treatment is more commonly used in
